Fingerprint
Dive into the research topics of 'Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pharmacokinetics and tolerability of cediranib, a potent VEGF signalling inhibitor, in cancer patients with hepatic impairment
Carla M L van Herpen, Ulrik Lassen, Ingrid M E Desar, Kathryn H Brown, Marcelo Marotti, Maja J A de Jonge